Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial

Stock Trading Ideas

Why Is UnitedHealth Stock Gaining Thursday?
Why Is UnitedHealth Stock Gaining Thursday?
Analyst Picks NVIDIA Over Every Other AI Chip Stock Right Now
Analyst Picks NVIDIA Over Every Other AI Chip Stock Right Now
Gold Price Sits At Critical Technical Support: History Says Buy The Breakdown
Gold Price Sits At Critical Technical Support: History Says Buy The Breakdown
Analyst Picks NVIDIA Over Every Other AI Chip Stock Right Now
Analyst Picks NVIDIA Over Every Other AI Chip Stock Right Now
Gold Price Sits At Critical Technical Support: History Says Buy The Breakdown
Gold Price Sits At Critical Technical Support: History Says Buy The Breakdown
What's Going On With Fulcrum Therapeutics Stock On Thursday?
What's Going On With Fulcrum Therapeutics Stock On Thursday?
OpenAI And Anthropic Are Scaling Faster Than Broadcom Expected Six Months Ago
OpenAI And Anthropic Are Scaling Faster Than Broadcom Expected Six Months Ago

Trading Ideas Recent News

CXApp Stock Skyrockets After EngineRoom Acquisition Announcement
CXApp Stock Skyrockets After EngineRoom Acquisition Announcement
CXApp Inc (NASDAQ: CXAI) shares are surging Thursday after it announced the acquisition of EngineRoom, an AI growth-tracking platform.
Five Below Delivers The Q1 Goods, Stock Gets Clobbered
Five Below Delivers The Q1 Goods, Stock Gets Clobbered
Five Below shares fall Thursday despite strong Q1 results. Loop Capital analyst weighs in.
Celsius Stock Is Tumbling Thursday: What's Driving The Action?
Celsius Stock Is Tumbling Thursday: What's Driving The Action?
Celsius Holdings shares are trading lower Thursday afternoon as traders revisit margin and product-mix debate despite insider buying.
Weight Watchers Broadens GLP-1 Reach As Eli Lilly Pursues New Kidney Disease Therapies
Weight Watchers Broadens GLP-1 Reach As Eli Lilly Pursues New Kidney Disease Therapies
Weight Watchers joins LillyDirect for GLP-1 access as Eli Lilly signs a kidney disease research pact with Ascidian worth up to $1.9 billion.
Crypto Markets Are Already Pricing SPCX: What Happens At IPO?
Crypto Markets Are Already Pricing SPCX: What Happens At IPO?
Robinhood, Webull, Interactive Brokers Set To Gain As PDT Rule Dies Today
Robinhood, Webull, Interactive Brokers Set To Gain As PDT Rule Dies Today
The Securities and Exchange Commission eliminates the PDT rule for accounts under $25,000, benefiting HOOD, BULL and IBKR.
Broadcom Stock Just Slid 15% — But The Selloff May Have Fixed A Bigger Problem
Broadcom Stock Just Slid 15% — But The Selloff May Have Fixed A Bigger Problem
Broadcom stock plunged after earnings, but the selloff reset RSI, reduced technical overextension and brought shares closer to key support.
Alnylam Eyes Faster Drug Discovery With AI Partnership Worth Up To $2 Billion
Alnylam Eyes Faster Drug Discovery With AI Partnership Worth Up To $2 Billion
Alnylam stock rises after a $2 billion AI-driven RNAi drug discovery collaboration with Inceptive as analysts maintain bullish price targets.
ServiceNow Shares Are Climbing: What's Driving The Move?
ServiceNow Shares Are Climbing: What's Driving The Move?
ServiceNow Inc (NYSE: NOW) shares are trading higher Thursday as traders lean into "AI won't kill software" narrative.
What's Going On With Abivax Stock On Thursday?
What's Going On With Abivax Stock On Thursday?
Abivax's Phase 3 ulcerative colitis data met remission goals, but cancer cases in the study raised safety questions and analyst caution.
Petco Stock Trades Lower After Mixed First-Quarter Results
Petco Stock Trades Lower After Mixed First-Quarter Results
Petco Health And Wellness Company shares are trading lower Thursday after reporting mixed Q1 results on Wednesday after the bell.
Lucid Shares Pause Thursday: What's Going On?
Lucid Shares Pause Thursday: What's Going On?
Lucid Group Inc (NASDAQ:LCID) shares are trading marginally higher Thursday as traders weigh robotaxi debate against dilution risk.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved